Skip to main content

The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030, predicts Roots Analysis

 

Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Microbial Contract Biomanufacturing Market, 2020-2030.

 

The report features an extensive study of the current market landscape and future opportunities associated with the microbial contract biomanufacturing market. It features a detailed analysis of key drivers and trends related to this evolving domain. In addition to other elements, the study includes:

§  A detailed review of the current landscape of companies offering contract manufacturing services.

§  Elaborate profiles of key players that specialize in offering services for contract biomanufacturing.

§  A competitiveness analysis, highlighting key players engaged in microbial based contract manufacturing, featuring insightful pictorial summaries and representations.

§  An analysis of the partnerships and expansions that have been established in this domain, in the recent past.

§  A competitiveness analysis, highlighting key players engaged in microbial based contract manufacturing, featuring insightful pictorial summaries and representations.

§  A detailed proprietary 2×2 representation to assess the current market scenario

§  An analysis of the initiatives of big biopharma players engaged in this domain.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Type of Product

§  API

§  FDF

 

§  Type of Biologic

§  Proteins

§  Enzymes

§  Growth Hormones

§  Antibody based Drugs

§  Others (plasmid DNA, probiotics, microbiome-based biologics)

 

§  Type of Microbial Expression System

§  Bacteria

§  Yeast

§  Others (Algae and fungi)

 

§  Scale of Operation

§  Commercial

§  Preclinical / Clinical

 

§  Type of End User

§  Small Companies

§  Mid-sized Companies

§  Large / Very Large Companies

 

§  Key Geographical Regions

§  North America

§  Europe

§  Asia Pacific

§  Middle East and North Africa

§  Latin America

To request a sample copy / brochure of this report, please visit this - https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market/request-sample.html

 

 

Key companies covered in the report

§  AGC Biologics

§  Aldevron

§  BioVectra

§  EirGenix

§  Etinpro

§  Eurogentec

§  Northway Biotechpharma

§  Ology Bioservices

§  Porton Biopharma

§  Stelis Biopharma

 

For additional details, please visit 

https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html or email sales@rootsanalysis.com

 

You may also be interested in the following titles:

1.     Drug Repurposing Service Providers Market, 2020 – 2030

2.     Antibody Discovery Services and Platforms Market (3rd Edition), 2020-2030

3.     Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020 - 2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

 

 

 

 

 

Labels:

Comments

Post a Comment

Popular posts from this blog

NOVEL DRUG RECONSTITUTION SYSTEMS - CURRENT MARKET LANDSCAPE

  Over the years, novel drug reconstitution systems have been widely adopted in the healthcare sector, owing to the numerous benefits offered by these products. During our research, we identified over 55 novel drug reconstitution systems , including prefilled syringes, cartridges and infusion bags being manufactured to ease the reconstitution of drugs packaged in containers. To order this detailed 180+ page report, please visit this - https://www.rootsanalysis.com/reports/drug-reconstitution-systems-market.html     Majority of the companies (32%) engaged in this domain are very large players. Examples of such companies include ( in alphabetical order, established after 1900 ) Baxter, Fresenius Kabi, ICU Medical, Shandong Pharmaceutical Glass, Terumo, Vetter Pharma and West Pharmaceutical Services. This is followed by the share of mid-sized players (29%) in this domain. P rominent examples of mid-sized players include ( in alphabetical order, established after...
Post a Comment
Read more

Manufacturing Market Continuous by Roots Analysis

    Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 .”   The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing §   Elaborate profiles of some o...
Post a Comment
Read more

Digital Health Market: Focus on Digital Therapeutics by Roots Analysis

  Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions   Roots Analysis has announced the addition of “ Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive), and Purpose of Solution (Medication Replacement and Medication Augmentation” report to its list of offerings.   According to experts, digital therapeutic solutions are primarily based on behavior modification and are designed to address a variety of therapeutic needs across a wide range of disease indications. On the other hand, several digital solutions have been developed to enable remote doctor-patient consultations. Such solutions witnessed a surge in ado...
Post a Comment
Read more